0.3299
Schlusskurs vom Vortag:
$0.3375
Offen:
$0.331
24-Stunden-Volumen:
351.74K
Relative Volume:
2.57
Marktkapitalisierung:
$6.02M
Einnahmen:
$294.20K
Nettoeinkommen (Verlust:
$-12.25M
KGV:
-0.0653
EPS:
-5.05
Netto-Cashflow:
$-10.77M
1W Leistung:
-11.79%
1M Leistung:
-13.86%
6M Leistung:
-15.52%
1J Leistung:
-40.03%
Aethlon Medical Inc Stock (AEMD) Company Profile
Firmenname
Aethlon Medical Inc
Sektor
Branche
Telefon
619-941-0360
Adresse
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Vergleichen Sie AEMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AEMD
Aethlon Medical Inc
|
0.3299 | 6.02M | 294.20K | -12.25M | -10.77M | -5.05 |
![]()
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
AEMD Trading Halted Pending Important Announcement | AEMD Stock News - GuruFocus
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagnostic, NanoSomix - openPR.com
aethlon medical announces reverse stock split effective june 6 By Investing.com - Investing.com South Africa
Aethlon Medical Approves Reverse Stock Split Plan - TipRanks
aethlon medical announces reverse stock split effective june 6 - Investing.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update - Defense World
Exosomes Market Projected to Reach USD 1,311.03 Million by - GlobeNewswire
Aethlon Adds to Board - Medical Product Outsourcing
FDA Grants Aethlon Compassionate Use Approval for its Hemopurifier to Help Fight Ebola - Medical Product Outsourcing
FDA OKs Aethlon to Export Hemopurifier to India - Medical Product Outsourcing
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtrati - GuruFocus
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtration System | AEMD Stock News - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showin - GuruFocus
Revolutionary Blood Filtration Device Shows 98.5% Success Rate in Cancer and Alzheimer's Treatment Study - Stock Titan
Aethlon Medical Approves Key Stockholder Proposals - TipRanks
Comparing Paragon 28 (NYSE:FNA) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Exosomes Market Size, Top Share, and Industry Analysis Report by 2033 - Straits Research
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 46.7% in March - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now - GlobeNewswire
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
HC Wainwright Reiterates Buy Rating for Aethlon Medical (NASDAQ:AEMD) - The AM Reporter
Aethlon Medical’s (AEMD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth - TipRanks
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Investorideas.com newswire
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Yahoo Finance
Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
HC Wainwright Boosts Earnings Estimates for Aethlon Medical - Defense World
Aethlon Medical (NASDAQ:AEMD) Receives “Buy” Rating from HC Wainwright - Defense World
Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 21.3% in January - Defense World
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):